Bonnet, Fabrice <br/><br/>
GLP-1 receptor agonist confer target organ protection in type 2 diabetes.  [electronic resource] 

 -  Diabetes & metabolism  04 2017 
 - 2S1-2S2 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1878-1780 
<br/><br/><label>Standard No.: </label>10.1016/S1262-3636(17)30066-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2--drug therapy<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Glucagon-Like Peptide-1 Receptor Agonists